Correlation Between Innate Pharma and Applied Molecular
Can any of the company-specific risk be diversified away by investing in both Innate Pharma and Applied Molecular at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Innate Pharma and Applied Molecular into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Innate Pharma and Applied Molecular Transport, you can compare the effects of market volatilities on Innate Pharma and Applied Molecular and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Innate Pharma with a short position of Applied Molecular. Check out your portfolio center. Please also check ongoing floating volatility patterns of Innate Pharma and Applied Molecular.
Diversification Opportunities for Innate Pharma and Applied Molecular
-0.52 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Innate and Applied is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Innate Pharma and Applied Molecular Transport in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Applied Molecular and Innate Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Innate Pharma are associated (or correlated) with Applied Molecular. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Applied Molecular has no effect on the direction of Innate Pharma i.e., Innate Pharma and Applied Molecular go up and down completely randomly.
Pair Corralation between Innate Pharma and Applied Molecular
Given the investment horizon of 90 days Innate Pharma is expected to under-perform the Applied Molecular. But the stock apears to be less risky and, when comparing its historical volatility, Innate Pharma is 1.36 times less risky than Applied Molecular. The stock trades about -0.03 of its potential returns per unit of risk. The Applied Molecular Transport is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 34.00 in Applied Molecular Transport on September 2, 2024 and sell it today you would lose (1.00) from holding Applied Molecular Transport or give up 2.94% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 8.06% |
| Values | Daily Returns |
Innate Pharma vs. Applied Molecular Transport
Performance |
| Timeline |
| Innate Pharma |
| Applied Molecular |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Innate Pharma and Applied Molecular Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Innate Pharma and Applied Molecular
The main advantage of trading using opposite Innate Pharma and Applied Molecular positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Innate Pharma position performs unexpectedly, Applied Molecular can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Applied Molecular will offset losses from the drop in Applied Molecular's long position.| Innate Pharma vs. Eliem Therapeutics | Innate Pharma vs. HCW Biologics | Innate Pharma vs. Inhibrx | Innate Pharma vs. Anebulo Pharmaceuticals |
| Applied Molecular vs. Aileron Therapeutics | Applied Molecular vs. Bio Path Holdings | Applied Molecular vs. Benitec Biopharma Ltd | Applied Molecular vs. Aerovate Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |